Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/17/1992 | EP0485608A4 Method for obtaining polypeptides in a cell-free translation system |
06/17/1992 | EP0484411A4 Prevention of internal initiation |
06/17/1992 | EP0479922A4 Monoclonal antibodies to c-reactive protein |
06/17/1992 | EP0357637B1 General cancer-associated scm-recognition factor, preparation and method of use |
06/17/1992 | EP0298991B1 Novel lectins derived from bacterial pili |
06/17/1992 | EP0215131B1 E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma |
06/17/1992 | DE4105374C1 New hybridoma Han-41 and its corresp. antibody - recognise glyco-protein found in broncho-alveolar system; useful as cell differentiation markers and to classify human lung |
06/17/1992 | DE4040043A1 New acid-stable and infectious human rhinovirus mutant - prepd. by incubating wild type virus at varying pH, useful for treating rhinoviral infection |
06/17/1992 | DE4039656A1 Arzneimittel, enthaltend das humane parathormon-fragment (1-37) in der form des amids oder ethylamids als aktiven wirkstoff A medicament containing the human parathyroid hormone fragment (1-37) in the form of the amide or ethylamids as an active ingredient |
06/16/1992 | US5122610 Renin inhibitor intermediates |
06/16/1992 | US5122603 Purified insulin mediators and purification process for same |
06/16/1992 | US5122602 Optical indicators; medical diagnosis; quantitative analysis; immunoassay |
06/16/1992 | US5122600 Using a carrier of specific particle size and one which does not absorb protein |
06/16/1992 | US5122599 CDNAS coding for members of the carcinoembryonic antigen family |
06/16/1992 | US5122597 Application of resins consisting of functional polymers as the stationary phase in affinity chromatography for the purification of growth factors, and corresponding purification method |
06/16/1992 | US5122596 Polypeptides useful as blockers of calcium channels |
06/16/1992 | US5122595 Modulates expression of extracellular enzymes in Streptomyces |
06/16/1992 | US5122594 Having specific arginines replaced by glutamine and/or serine |
06/16/1992 | US5122511 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 |
06/16/1992 | US5122471 Cloned genes coding for avian coccidiosis antigens which induce a cell-mediated immune response |
06/16/1992 | US5122468 Hut-78 cell lines infected with HTLV-III which secrete gp160 |
06/16/1992 | US5122463 Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor |
06/16/1992 | US5122459 Gene encoding biologically active human interleukin 1 |
06/16/1992 | US5122458 Use of a bgh gdna polyadenylation signal in expression of non-bgh polypeptides in higher eukaryotic cells |
06/16/1992 | US5122457 Expression systems utilizing bacteriophage t7 promoters, gene sequences, and t7 rna polymerase |
06/16/1992 | US5122448 Mixing sample with polypeptide, determining presence of immunoreaction |
06/16/1992 | US5122447 Nucleocapsid proteins of the pseudorabies virus |
06/16/1992 | CA1303793C Process for selective peptide bond cleavage |
06/16/1992 | CA1303627C Nona and decapeptide analogs of lhrh useful as lhrh antagonists |
06/16/1992 | CA1303531C Choriocarcinoma monoclonal antibodies and antibody panels |
06/16/1992 | CA1303530C EXPRESSION VECTORS AND THEIR USE FOR THE PREPARATION OF A PROTEIN HAVING HUMAN .alpha. -ANTITRYPSIN ACTIVITY |
06/16/1992 | CA1303529C Human interferon- _polypeptide derivative |
06/16/1992 | CA1303528C Human interferon- _polypeptide derivative |
06/16/1992 | CA1303527C Cross-over linker dna sequence |
06/16/1992 | CA1303525C Rotavirus reassortant vaccine |
06/16/1992 | CA1303496C Ck-mm myocardial infarction immunoassay |
06/15/1992 | WO1992010506A1 Human retrovirus receptor and dna coding therefor |
06/15/1992 | CA2097705A1 Human retrovirus receptor and dna coding therefor |
06/15/1992 | CA2057534A1 Acid amides |
06/14/1992 | WO1992010576A1 Fusion polypeptides |
06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
06/14/1992 | CA2094512A1 Fusion polypeptides |
06/11/1992 | WO1992010582A1 Monokine mig induced by ifn-gamma |
06/11/1992 | WO1992009893A1 DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN(a) |
06/11/1992 | WO1992009699A1 Monoclonal antibody for use in diagnosing alzheimer's disease, hybridoma secreting said antibody and preparation method therefor |
06/11/1992 | WO1992009698A1 Expression of pace in host cells and methods of use thereof |
06/11/1992 | WO1992009697A1 USE OF A BONE MORPHOGENETIC PROTEIN IN SYNERGISTIC COMBINATION WITH TGF-β FOR BONE REPAIR |
06/11/1992 | WO1992009695A1 Structural proteins from artificial genes |
06/11/1992 | WO1992009693A1 Human parainfluenza virus type 4a fusion protein and gene which codes for the same |
06/11/1992 | WO1992009691A1 New variants derived from interferons of type i, production process thereof and their applications |
06/11/1992 | WO1992009690A2 Enrichment method for variant proteins with altered binding properties |
06/11/1992 | WO1992009685A1 Control of plant cell proliferation and growth |
06/11/1992 | WO1992009684A1 Recombinant avirulent salmonella antifertility vaccines |
06/11/1992 | WO1992009634A1 Non-a non-b hepatitis virus antigen protein |
06/11/1992 | WO1992009632A1 Fragments of the env protein of the feline immunodeficiency virus, antibodies and their applications in diagnosis |
06/11/1992 | WO1992009629A1 Protein presenting an activity of the cytokine type, recombinant dna, expression vector and hosts used to produce such protein |
06/11/1992 | WO1992009628A1 Synthetic immunoactive peptides having immunomodulating and therapeutic activities |
06/11/1992 | WO1992009625A1 Conformationally constrained peptides i |
06/11/1992 | WO1992009623A1 METHOD FOR PREPARING A PROTEIN COMPRISING AT LEAST ONE INTRAMOLECULAR DISULPHIDE BOND BY OXIDATION, AT A pH OF LESS THAN 5.0, OF THE REDUCED RECOMBINANT PROTEIN |
06/11/1992 | WO1992009621A1 Biologically active bactericidal/permeability-increasing protein fragments |
06/11/1992 | WO1992009617A1 Cell stress transcriptional factors |
06/11/1992 | WO1992009305A1 Anti cd-4 antibodies blocking hiv-induced syncytia |
06/11/1992 | WO1992009303A1 Albumin preparation and preservation thereof |
06/11/1992 | WO1992009302A1 Methods and compositions for diagnosing chronic immune thrombocytopenic purpura |
06/11/1992 | WO1992009301A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing |
06/11/1992 | WO1992009298A1 The delay, prevention and/or reversal of cell senescence |
06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
06/11/1992 | WO1992009296A1 A peptide which regulates weight gain in mammals |
06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/11/1992 | WO1992009200A1 Novel polypeptides for promoting cell attachment |
06/11/1992 | WO1992007254A3 Use of disulphide bidged substances |
06/11/1992 | DE4139840A1 Compsns. contg. antigen from cell-associated protein of H. pylorus - useful for sensitive selective detection of antibodies with less false positives and negatives |
06/11/1992 | DE4038947A1 Dithiolano- und dithianoglycin-haltige renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Dithiolano- and dithianoglycin-containing peptide renininhibitorische, process for their production and their use in medicinal products |
06/11/1992 | DE4038921A1 Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Renininhibitorische peptide from cyclohexylstatin-type, process for their production and their use in medicinal products |
06/11/1992 | CA2405246A1 Enrichment method for variant proteins with alterred binding properties |
06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/11/1992 | CA2074802A1 Interferons derived mutants of type i, their production process and applications |
06/11/1992 | CA2073564A1 Method for preparing a protein comprising at least one intramolecular disulphide bond by oxidation, at a ph of less than 5.0, of the reduced recombinant protein |
06/11/1992 | CA2057269A1 Process for the enzymatic preparation of grf(1-44)nh2 |
06/10/1992 | EP0489711A2 Method for producing human growth hormone |
06/10/1992 | EP0489201A1 Method for the isolation and expression of a gene which codes for streptokinase, nucleotide sequence obtained, recombinant DNA and transformed microorganisms |
06/10/1992 | EP0489180A1 Anticoagulant polypeptides |
06/10/1992 | EP0489149A1 Probes for detecting mutant p53 |
06/10/1992 | EP0489113A1 The use of thioredoxin in the treatment of malignantly transformed cells in animals and man |
06/10/1992 | EP0489062A1 Bone-specific protein |
06/10/1992 | EP0489058A1 Cystic fibrosis gene |
06/10/1992 | EP0437576A4 Homologous recombination for universal donor cells and chimeric mammalian hosts |
06/10/1992 | EP0174367B1 Hosts and methods for producing recombinant products in high yields |
06/10/1992 | CN1061814A Process for spinning polypeptide fibers |
06/09/1992 | US5120834 Fibrin-specific monoclonal antibody |
06/09/1992 | US5120833 Method of producing grafts |
06/09/1992 | US5120832 Having specified dna sequence and free from other proteins; viricides, antitumor agents |
06/09/1992 | US5120830 Anticoagulant |
06/09/1992 | US5120829 Hydrophobic attachment site for adhesion peptides |
06/09/1992 | US5120828 Synthetic polypeptide with laminin activity |
06/09/1992 | US5120715 Method for purifying fibroblast growth factor protein |
06/09/1992 | US5120712 Insulinotropic hormone |
06/09/1992 | US5120653 Vector comprising DNA sequence coding for enzyme-donor polypeptide |
06/09/1992 | US5120642 Medical diagnosis |